Chronic administration of oren-gedoku-to (TJ15) inhibits ischemia-induced changes in brain indoleamine metabolism and muscarinic receptor binding in the mongolian gerbil

Neurochemical Research

Volumn 22, Issue 1, 1997, Pages 33-36

  Kabuto, Hideaki ^a   Asanuma, Masato ^a   Nishibayashi, Sakiko ^a   Lida, Motoyuki ^a   Ogawa, Norio ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Acctylcholine; Monoamine metabolism; Muscarinic receptor; Oren gedoku to (TJ15); Serotonin; Transient ischemia

Indexed keywords

INDOLEAMINE; MUSCARINIC RECEPTOR; ORENGEDOKU TO;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN ISCHEMIA; BRAIN METABOLISM; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DRUG EFFECT; GERBIL; MALE; MONOAMINE METABOLISM; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RECEPTOR BINDING;

ACETYLCHOLINE; ANIMALS; DRUGS, CHINESE HERBAL; GERBILLINAE; HYDROXYINDOLEACETIC ACID; ISCHEMIC ATTACK, TRANSIENT; MALE; PROSENCEPHALON; RECEPTORS, MUSCARINIC; SEROTONIN; TIME FACTORS;

ANIMALIA; GERBILLINAE; MERIONES UNGUICULATUS;

EID: 0031044351     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/a:1027369119224     Document Type: Article

References (27)

1. Klisch, J., and Bode Greuel, K. M. 1992. Ketanserin reduces neuronal calcium accumulation and cell death in the hippocampus of the Mongolian gerbil after transient forebrain ischemia. Brain Res. 578:1-7.
2. Frolich, L., Din-, A., Riederer, P., and Hoyer, S. 1993. Effects of long-term recovery from transient cerebral ischemia in rat brain: tissue levels of acctylcholine, monoamines, and their metabolites. Neurochem. Res. 18:1239-1244.
3. Araki, T., Kato, H., and Kogure, K. 1992. Postischemic alteration of muscarinic acetylcholine and adenosine Al binding sites in gerbil brain. Protective effects of a novel vinca alkaloid derivative, vinconate, and pentobarbital using an autoradiographic study. Res. Exp. Med. Berl. 192:79-88.
4. Katsura, M., lino, T., and Kuriyama, K. 1992. Changes in content of neuroactive amino acids and acetylcholine in the rat hippocampus following transient forebrain ischemia. Neurochem. Int. 21:243-249.
5. Ogawa, N., Asanuma, M., Mizukawa, K., Hirata, H., Chou, H., and Mori, A. 1992. Post-ischemic administration of bifemelane hydrochloride prohibits ischemia-induced depletion of the muscarinic M1-receptor and its mRNA in the gerbil hippocampus. Brain Res. 591: 171-175.
6. Ogawa, N., Tanaka, K., Kondo, Y., Asanuma, M., Mizukawa, K., and Mori, A. 1993. The preventive effect of cyclosporin A, an immuno-suppressant, on the late onset reduction of muscarinic acetylcholine receptors in gerbil hippocampus after transient forebrain ischemia. Neurosci. Lett. 152:173-176.
7. Kondo, Y., Ogawa, N., Asanuma, M., Nishibayashi, S., Iwata, E., and Mori, A. 1995. Cyclosporin A prevents ischemia-induced reduction of muscarinic acetylcholine receptors with suppression of microglial activation in gerbil hippocampus, Neurosci. Res. 22:123-127.
8. Haba, K., Ogawa, N., and Mori, A. 1990. The effect of Sho-saiko-to-go-keishi-ka-shakuyaku-to (TJ-960) on ischemia-induced changes of brain acetylcholinc and monoamine levels in gerbils, Neurochem. Res. 15:487-493.
9. Haba, K., Ogawa, N., Asanuma, M., Hirata, H., and Mori, A. 1992. Comparison of the effects of bifemelane hydrochloride, idebenone and indeloxazine hydrochloride on ischemia-induced changes in brain monoamines and their metabolites in gerbils. J. Neural Transm. 88: 187-198.
10. Hasegawa, T. 1984. Clinicai effect of Oren-gedoku-to on cerebrovascular disorders. In: Oda T et al, eds. Recent advances in traditional medicine in East Asia, ICS693. Tokyo: Excepta Medica. 209-218.
11. Ozaki, M., Ohta, H., and Sekine, I. 1985. Effect of Choto-san and Oren-gedoku-to on blood pressure in rat (SHR-SP) susceptible to cerebral apoplexy. J. Med. Pharm. Soc. Wakan-Yaku. 2:560-561. (In Japanese).
12. Kuwaki, T. 1979. Effects of Oren-gedoku-to and other Kampo prescriptions in cases of hypertension. Nihon Tokyo Igakkaisi. 29:105-113.
13. Glowinski, J., and Iversen, L. L. 1966. Regional studies of catecholamines in the rat brain. J. Neurochem., 13:655-669.
14. Kabuto, H., Yokoi, I., Mori, A., Murakami, M., and Sawada, S. 1995. Neurochemical changes related to aging in the senescence-accelerated mouse brain and the effect of chronic administration of nimodipine. Mech. Ageing Dev. 80:1-9.
15. Kabuto, H., Yokoi, I., and Mori, A. 1992. Monoamine metabolites, iron induced seizures, and the anticonvulsant effect of tannins. Neurochem. Res, 17:585-590.
16. Fujimori, K., and Yamamoto, K. 1987. Determination of acetylcholine in perchlorale extracts of brain tissue using liquid chromatography-chromatography with an immobilized-enzyme reactor. J. Chromotogr., 414:167-173.
17. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. 1951. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193:265-275.
18. Ogawa, N., Mizuno, S., Nukina, I., Tsukamoto, S., and Mori, A. 1983. Chronic thyrotropin releasing hormone (TRH) administration on TRH receptors and muscarinic cholinergic receptors in CNS, Brain Res. 263:348-350.
19. Deutch, J. A., Hamburg, M. D., and Dahl, H. 1966. Anti-choline esterase-induced amnesia and its temporal aspects, Science, 151:221-223.
20. Gibson, G. E., and Duffy, T. E. 1981. Impaired synthesis of acetylcholine by mild hypoxic hypoxia or nitrous oxide. J. Neurochem. 36: 28-33.
21. Gibson, G. E., Shimada, M., and Biass, J. P. 1978. Alterations in acetylcholine synthesis and cyclic nucleotides in mild cerebral hypoxia. J. Neurochem. 31:757-760.
22. Hammer, R., and Giachetti, A. 1984. Selective muscarinic receptor antagonists, Trends Pharmacol. Sci., 5:18-20.
23. 3H]pirenzepine. J. Neurochem. 46:274-279.
24. Mash, D. C., Flynn, D. D., and Rotter, L. T. 1985, Loss of M2 muscarinic receptors in the cerebral cortex in Alzheimer's disease and experimental cholinergic denervation, Science. 228:1115-1117.
25. Haba, K., Ogawa, N., Mizukawa, K., and Mori, A. 1991. Time course of changes in lipid peroxidation, pre- and postsynaptic cholinergic indices, NMDA receptor binding and neuronal death in the gerbil hippocampus following transient ischemia. Brain Res. 540:116-122.
26. Nagasawa, H., and Kogure, K. 1988. Efficacy of Oren-gedoku-to (TJI5) in a model of chronic cerebral ischemia. In: Hosoya, E. and Yamamura, Y. eds. Recent advances in Pharmacology of Kampo (Japanese herbal) medicines. Tokyo: Excepta Medica. 213-218.
27. Fushitani, S., Tsuchiya, K., Minakuchi, K., Takasugi, M., and Murakami, K. 1994. Studies on attenuation of post-ischemic brain injury by kampo medicines-inhibitory effects of free radical production. I. Yakugaku-Zasshi. 114:388-394. in Japanese.